Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2009 1
2010 1
2011 2
2012 2
2013 3
2014 1
2015 1
2016 3
2017 3
2019 1
2020 3
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
AmBisome Monotherapy and Combination AmBisome-Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 Trial.
Burza S, Mahajan R, Kazmi S, Alexander N, Kumar D, Kumar V, Lasry E, Harshana A, de Lima Pereira A, Das P, Verma N, Das VNR, Lal CS, Rewari B, Goyal V, Rijal S, Alves F, Gill N, Pandey K. Burza S, et al. Among authors: lal cs. Clin Infect Dis. 2022 Oct 12;75(8):1423-1432. doi: 10.1093/cid/ciac127. Clin Infect Dis. 2022. PMID: 35147680 Free PMC article. Clinical Trial.
Advanced case of PKDL due to delayed treatment: A rare case report.
Topno RK, Rabi Das VN, Kumar M, Madhukar M, Pandey K, Verma N, Agrawal K, Lal CS, Siddiqui NA, Bimal S, Das P. Topno RK, et al. Among authors: lal cs. PLoS Negl Trop Dis. 2020 Mar 23;14(3):e0008052. doi: 10.1371/journal.pntd.0008052. eCollection 2020 Mar. PLoS Negl Trop Dis. 2020. PMID: 32203500 Free PMC article.
A randomized, open-label study to evaluate the efficacy and safety of liposomal amphotericin B (AmBisome) versus miltefosine in patients with post-kala-azar dermal leishmaniasis.
Pandey K, Pal B, Siddiqui NA, Lal CS, Ali V, Bimal S, Kumar A, Verma N, Das VNR, Singh SK, Topno RK, Das P. Pandey K, et al. Among authors: lal cs. Indian J Dermatol Venereol Leprol. 2021 Jan-Feb;87(1):34-41. doi: 10.25259/IJDVL_410_19. Indian J Dermatol Venereol Leprol. 2021. PMID: 33580944 Free article. Clinical Trial.
Para-kala-azar dermal Leishmaniasis cases in Indian subcontinent - A case series.
Kumar R, Das VN, Topno RK, Pal B, Imam A, Agrawal K, Singh A, Murti K, Lal CS, Verma N, Das P, Pandey K. Kumar R, et al. Among authors: lal cs. Pathog Glob Health. 2016 Oct-Dec;110(7-8):326-329. doi: 10.1080/20477724.2016.1258163. Epub 2016 Nov 22. Pathog Glob Health. 2016. PMID: 27871210 Free PMC article. No abstract available.
25 results